logo
  • Home
  • Solution
  • Impact
  • R&D
    • Science
    • Publications
    • STEP study
    • Xinnate’s Expanded Access Policy
  • About
    • Team and Board
  • News and Events
    • All News
    • All Events
    • All Press Releases
  • Contact

The 3rd World Congress on Rare Skin Diseases: 01-03 July 2026

26 May, 2026
|In Events
|By Anna-Karin Lindqvist

The 3rd World Congress on Rare Skin Diseases — a place to deepen knowledge, discover the latest research, and connect with people who truly care about improving life for EB patients.

The 3rd World Congress on Rare Skin Diseases 2026
01-03 July 2026
Versailles, France

https://www.wcrsd.com/en/ 

 

Recent Posts

  • 5th Öresund Peptide Symposium: 24 September 2026
  • Xinnate Receives FDA Rare Pediatric Disease Designation for TCP-25 for the Treatment of Epidermolysis Bullosa
  • debra Care Conference: 26-29 July 2026
  • Xinnate Appoints Erik Kinnman as Chairman of the Board
  • Xinnate receives FDA Fast Track Designation for TCP-25 for the Treatment of Epidermolysis Bullosa

Archives

  • September 2026
  • July 2026
  • June 2026
  • May 2026
  • February 2026
  • January 2026
  • December 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • January 2025
  • December 2024
  • September 2024
  • May 2024
  • March 2024
  • February 2024
  • March 2023
  • October 2022
  • September 2022
  • July 2022
  • March 2022
  • August 2021
  • October 2020
  • January 2020
  • Prev
  • Next
© 2026 Xinnate. All rights reserved